Skip to main content

Table 1 Summary of the selected studies

From: Efficacy and effectiveness of Ceftaroline Fosamil in patients with pneumonia: a systematic review and meta-analysis

First Author

Title

Publication year

Type of study

Country

Study period

Jandourek et al. [9]

Efficacy of ceftaroline fosamil for bacteremia associated with community-acquired bacterial pneumonia

2014

Clinical Trial

USA

Jul 2007-Dec 2008

File et al. [10]

FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia

2011

Clinical Trial

USA

Jan 2008-Dec 2008

Low et al. [11]

FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia

2011

Clinical Trial

USA

Jul 2007-Aug 2008

Shorr et al. [12]

Assessment of ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia due to Streptococcus pneumoniae: insights from two randomized trials

2013

Clinical Trial

USA

Jul 2007-Dec 2008

File et al. [13]

Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus. Ceftriaxone in patients with community-acquired pneumonia

2010

Clinical Trial

USA

Jul 2007-Dec 2008

Zhong et al. [14]

Ceftaroline fosamil versus ceftriaxone for the treatment of Asian patients with community-acquired pneumonia: a randomised, controlled, double-blind, phase 3, non-inferiority with nested superiority trial

2015

Clinical Trial

China, India, South Korea, Taiwan, Vietnam

Dec 2011-Apr 2013

Arshad et al. [15]

Ceftaroline fosamil for treatment of Methicillin-Resistant Staphylococcus aureus hospital-acquired pneumonia and health care-associated pneumonia. A 5-year matched case-control evaluation of epidemiology and outcomes

2016

Case-control study

USA

Jan 2009-May 2013

Eckburg et al. [22]

Day 4 Clinical response of ceftaroline fosamil versus ceftriaxone for community-acquired bacterial pneumonia

2012

Retrospective integrated analysis of FOCUS trials

USA

Jul 2007-Dec 2008

Guervil et al. [16]

Ceftaroline fosamil as first-line versus second-line treatment for acute bacterial skin and skin structure infections (ABSSSI) or community-acquired bacterial pneumonia (CABP)

2015

Retrospective Cohort study

USA

Aug 2011-Feb 2013

Udeani et al... [17]

Ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia in elderly patients

2014

Retrospective Cohort study

USA

Aug 2011-Ap 2013

Ramani et al..... [18]

Contemporary use of ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia: CAPTURE study experienc

2014

Retrospective Cohort study

USA

Aug 2011-Feb 2013

Vasquez et al... [19]

Ceftaroline Fosamil for the Treatment of Staphylococcus aureus Bacteremia Secondary to Acute Bacterial Skin and Skin Structure Infections or Community-Acquired Bacterial Pneumonia

2015

Retrospective Cohort study

USA

Aug 2011-Feb 2013

Casapao et al... [20]

Large retrospective study evaluation of the effectiveness and safety of Ceftaroline fosamil therapy

2014

Retrospective observational study

USA

Jan 2011-Jun 2013

Kaye et al. [21]

Ceftaroline fosamil for the treatment of hospital acquired pneumonia and ventilator associated pneumonia

2015

Retrospective Cohort study

USA

Sep 2013-Mar 2014